81 related articles for article (PubMed ID: 9876528)
1. Fabrication of multiunit controlled-release phenylpropanolamine hydrochloride tablets.
Mitrevej A; Sinchaipanid N; Natpoolwat N; Naratikornrit N
Drug Dev Ind Pharm; 1998 Aug; 24(8):793-6. PubMed ID: 9876528
[TBL] [Abstract][Full Text] [Related]
2. Design and study of ibuprofen disintegrating sustained-release tablets comprising coated pellets.
Abbaspour MR; Sadeghi F; Afrasiabi Garekani H
Eur J Pharm Biopharm; 2008 Mar; 68(3):747-59. PubMed ID: 17977701
[TBL] [Abstract][Full Text] [Related]
3. Preparation and in vitro/in vivo evaluation of sustained-release metformin hydrochloride pellets.
Hu LD; Liu Y; Tang X; Zhang Q
Eur J Pharm Biopharm; 2006 Oct; 64(2):185-92. PubMed ID: 16797948
[TBL] [Abstract][Full Text] [Related]
4. Sustained-release dosage form of phenylpropanolamine hydrochloride (3). Application of factorial design.
Sevgi F; Ozyazici M; Güneri T
J Microencapsul; 1994; 11(4):439-44. PubMed ID: 7931943
[TBL] [Abstract][Full Text] [Related]
5. Sustained release phenylpropanolamine hydrochloride from ATO 888 matrix.
Perez MA; Ghaly ES; Marti A
P R Health Sci J; 1993 Dec; 12(4):263-7. PubMed ID: 8140204
[TBL] [Abstract][Full Text] [Related]
6. Sustained-release dosage form of phenylpropanolamine hydrochloride. Part II: Formulation and in vitro release kinetics from tableted microcapsules.
Sevgi F; Ozyazici M; Güneri T
J Microencapsul; 1994; 11(3):335-44. PubMed ID: 8064557
[TBL] [Abstract][Full Text] [Related]
7. The effect of the ratio of two acrylic polymers on the in vitro release kinetics of ketoprofen from pellets prepared by extrusion and spheronisation technique.
Kibria G; Ul-Jalil R
Pak J Pharm Sci; 2008 Apr; 21(2):92-7. PubMed ID: 18390436
[TBL] [Abstract][Full Text] [Related]
8. Examination of aqueous oxidized cellulose dispersions as a potential drug carrier. II. In vitro and in vivo evaluation of phenylpropanolamine release from microparticles and pellets.
Zhu L; Kumar V; Banker GS
AAPS PharmSciTech; 2004 Aug; 5(4):e70. PubMed ID: 15760067
[TBL] [Abstract][Full Text] [Related]
9. Exploring the potential of a highly compressible microcrystalline cellulose as novel tabletting excipient in the compaction of extended-release coated pellets containing an extremely water-soluble model drug.
Zeeshan F; Peh KK; Tan YT
AAPS PharmSciTech; 2009; 10(3):850-7. PubMed ID: 19554454
[TBL] [Abstract][Full Text] [Related]
10. Microencapsulated Eudragit RS30D-coated controlled-release pellets: the influence of dissolution variables and topographical evaluation.
Govender T; Dangor CM; Chetty DJ
J Microencapsul; 1997; 14(1):1-13. PubMed ID: 8994071
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of multiple dosage bioavailability between phenylpropanolamine controlled release suspension and conventional tablet in healthy volunteers].
Shen YX; Xu CD; Gao XH; Lin DC; Liu GL
Yao Xue Xue Bao; 1995; 30(2):157-60. PubMed ID: 7785434
[TBL] [Abstract][Full Text] [Related]
12. Statistical optimization of indomethacin pellets coated with pH-dependent methacrylic polymers for possible colonic drug delivery.
Akhgari A; Afrasiabi Garekani H; Sadeghi F; Azimaie M
Int J Pharm; 2005 Nov; 305(1-2):22-30. PubMed ID: 16236475
[TBL] [Abstract][Full Text] [Related]
13. Stability study of ambroxol hydrochloride sustained release pellets coated with acrylic polymer.
Kibria G; Islam KM; Jalil RU
Pak J Pharm Sci; 2009 Jan; 22(1):36-43. PubMed ID: 19168418
[TBL] [Abstract][Full Text] [Related]
14. Citric acid as a solid-state plasticizer for Eudragit RS PO.
Schilling SU; Shah NH; Malick AW; Infeld MH; McGinity JW
J Pharm Pharmacol; 2007 Nov; 59(11):1493-500. PubMed ID: 17976259
[TBL] [Abstract][Full Text] [Related]
15. Evaluating tamsulosin hydrochloride-released microparticles prepared using single-step matrix coating.
Maeda A; Shinoda T; Ito N; Baba K; Oku N; Mizumoto T
Int J Pharm; 2011 Apr; 408(1-2):84-90. PubMed ID: 21291970
[TBL] [Abstract][Full Text] [Related]
16. Influence of Eudragit NE 30 D blended with Eudragit L 30 D-55 on the release of phenylpropanolamine hydrochloride from coated pellets.
Zheng W; McGinity JW
Drug Dev Ind Pharm; 2003 Mar; 29(3):357-66. PubMed ID: 12741617
[TBL] [Abstract][Full Text] [Related]
17. Investigation on drug dissolution and particle characteristics of pellets related to manufacturing process variables of high-shear granulation.
Dévay A; Mayer K; Pál S; Antal I
J Biochem Biophys Methods; 2006 Nov; 69(1-2):197-205. PubMed ID: 16650480
[TBL] [Abstract][Full Text] [Related]
18. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
[TBL] [Abstract][Full Text] [Related]
19. Compressibility of floating pellets with verapamil hydrochloride coated with dispersion Kollicoat SR 30 D.
Sawicki W; Lunio R
Eur J Pharm Biopharm; 2005 May; 60(1):153-8. PubMed ID: 15848067
[TBL] [Abstract][Full Text] [Related]
20. Relationship between drug dissolution and leaching of plasticizer for pellets coated with an aqueous Eudragit S100:L100 dispersion.
Bando H; McGinity JW
Int J Pharm; 2006 Oct; 323(1-2):11-7. PubMed ID: 16815652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
